The Impact of Low-Dose Esketamine Combined With Ciprofol on the Quality of Early Postoperative Recovery Among Elderly Patients Undergoing Painless Gastroscopy

NCT06617039•Northern Jiangsu People's Hospital

Summary

To explore the impact of esketamine combined with ciprofol on the quality of early postoperative recovery in elderly patients undergoing painless gastroscopy, as well as the effectiveness and safety of this regimen.

Eligibility

Age

60 - 75 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1\. Scheduled painless gastroscopy examination and treatment
•2\. Age 60-75 years old
•3\. ASA grade Ⅰ-Ⅱ
•4\. The respiratory tract is unobstructed and there is no difficult airway
•5\. No history of allergy to etomidate and cyclopropofol
•6\. Participants with normal heart, liver, lung, and kidney functions
•7\. Able to complete the QoR-15, MMSE, and HADS scale assessments
•8\. lnformed consent, voluntary participation in the trial, and signed by the patient informed consent

Exclusion Criteria

•1\. Participants with concurrent dysfunction of major organs.
•2\. Participants with a history of mental illness and abuse of sedative drugs
•3\. Participants with allergies or contraindications to the study drugs
•4\. Participants with severe visual, auditory, or speech communication impairments
•5\. Participants with acute gastrointestinal inflammation or obstruction
•6\. History of uncontrolled diabetes, hypertension, and hypotension
•7\. Participants with malignant tumors, severe hyperkalemia, bronchial asthma, or excessive obesity (BMI \> 30kg/m2)
•8\. Participants with aneurysmal vascular diseases of the thoracic and abdominal aorta, intracranial and peripheral arterial vessels.
•9\. Unable to cooperate with the QoR-15, MMSE, and HADS scale assessments

Locations (1)

Subei People's Hospital of Jiangsu Province

Yangzhou, Jiangsu, China

Key Dates

Start Date

October 10, 2024

Primary Completion Date

July 15, 2025

Completion Date

July 15, 2025

Last Updated

May 7, 2025

Enrollment

376

ESTIMATED participants

Conditions

Quality of Postoperative Recovery

Interventions

Remifentanil and ciprofol

DRUG

esketamine 0.3mg/kg and ciprofol

DRUG

esketamine 0.5mg/kg and ciprofol

DRUG

Ciprofol

DRUG